Year |
Citation |
Score |
2023 |
Anderson JD. Advances in Stem Cell Immunotherapy. Stem Cells (Dayton, Ohio). 41: 307-309. PMID 37098181 DOI: 10.1093/stmcls/sxad011 |
0.32 |
|
2022 |
DeFelice BC, Fiehn O, Belafsky P, Ditterich C, Moore M, Abouyared M, Beliveau AM, Farwell DG, Bewley AF, Clayton SM, Archard JA, Pavlic J, Rao S, Kuhn M, Deng P, ... ... Anderson JD, et al. Polyamine Metabolites as Biomarkers in Head and Neck Cancer Biofluids. Diagnostics (Basel, Switzerland). 12. PMID 35453845 DOI: 10.3390/diagnostics12040797 |
0.678 |
|
2021 |
Park UC, Park SS, Kim BH, Park SW, Kim YJ, Cary W, Anderson JD, Nolta JA, Yu HG. Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration. Annals of Translational Medicine. 9: 1275. PMID 34532412 DOI: 10.21037/atm-20-4662 |
0.704 |
|
2021 |
Nativ-Zeltzer N, Kuhn MA, Evangelista L, Anderson JD, Nolta JA, Farwell DG, Canestrari E, Jankowski RJ, Belafsky PC. Autologous Muscle-Derived Cell Therapy for Swallowing Impairment in Patients Following Treatment for Head and Neck Cancer. The Laryngoscope. PMID 33988246 DOI: 10.1002/lary.29606 |
0.665 |
|
2020 |
Nativ-Zeltzer N, Ueha R, Nachalon Y, Ma B, Pastenkos G, Swackhamer C, Bornhorst GM, Lefton-Greif MA, Anderson JD, Belafsky PC. Inflammatory Effects of Thickened Water on the Lungs in a Murine Model of Recurrent Aspiration. The Laryngoscope. PMID 32770795 DOI: 10.1002/Lary.28948 |
0.46 |
|
2020 |
Börger V, Weiss DJ, Anderson JD, Borràs FE, Bussolati B, Carter DRF, Dominici M, Falcón-Pérez JM, Gimona M, Hill AF, Hoffman AM, de Kleijn D, Levine BL, Lim R, Lötvall J, et al. ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19. Cytotherapy. PMID 32425691 DOI: 10.1016/J.Jcyt.2020.05.002 |
0.395 |
|
2020 |
Halmai JANM, Deng P, Gonzalez CE, Coggins NB, Cameron D, Carter JL, Buchanan FKB, Waldo JJ, Lock SR, Anderson JD, O'Geen H, Segal DJ, Nolta J, Fink KD. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene. Nucleic Acids Research. PMID 31925439 DOI: 10.1093/Nar/Gkz1214 |
0.725 |
|
2019 |
Clayton SM, Archard J, Wagner J, Farwell DG, Bewley AF, Beliveau A, Birkeland AC, Rao S, Abouyared M, Belafsky P, Anderson JD. Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells. Stem Cells and Development. PMID 31856674 DOI: 10.1089/Scd.2019.0197 |
0.597 |
|
2019 |
Elahi FM, Farwell DG, Nolta JA, Anderson JD. Concise Review: Preclinical Translation of Exosomes Derived from Mesenchymal Stem/Stromal Cells. Stem Cells (Dayton, Ohio). PMID 31381842 DOI: 10.1002/Stem.3061 |
0.718 |
|
2019 |
Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, ... ... Anderson JD, et al. Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochemical and Biophysical Research Communications. PMID 30926165 DOI: 10.1016/J.Bbrc.2019.03.119 |
0.737 |
|
2019 |
Yuan OD, Lin C, Wagner J, Archard J, Deng P, Halmai J, Bauer G, Fink K, Fury B, Perotti N, Walker J, Pollock K, Apperson M, Butters J, Belafsky P, ... ... Anderson JD, et al. Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells and Development. PMID 30638129 DOI: 10.1089/Scd.2018.0200 |
0.743 |
|
2017 |
Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Current Eye Research. 1-10. PMID 28636406 DOI: 10.1080/02713683.2017.1319491 |
0.749 |
|
2016 |
Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. Advances in bone marrow stem cell therapy for retinal dysfunction. Progress in Retinal and Eye Research. PMID 27784628 DOI: 10.1016/J.Preteyeres.2016.10.002 |
0.735 |
|
2016 |
Velichko S, Zhou X, Zhu L, Anderson JD, Wu R, Chen Y. A Novel Nuclear Function for the Interleukin-17 Signaling Adaptor Protein Act1. Plos One. 11: e0163323. PMID 27723765 DOI: 10.1371/Journal.Pone.0163323 |
0.723 |
|
2016 |
Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta JA. Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opinion On Biological Therapy. PMID 27159050 DOI: 10.1080/14712598.2016.1183641 |
0.749 |
|
2016 |
Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Wheelock V, Segal DJ, Nolta JA. Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington's disease fibroblasts. Cell Transplantation. PMID 26850319 DOI: 10.3727/096368916X690863 |
0.739 |
|
2016 |
Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, et al. Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via NFkB Signaling. Stem Cells (Dayton, Ohio). PMID 26782178 DOI: 10.1002/Stem.2298 |
0.786 |
|
2016 |
Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, Anderson JD, McGee JL, et al. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's disease Mouse Models. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26765769 DOI: 10.1038/Mt.2016.12 |
0.771 |
|
2016 |
Anderson JD, Pham MT, Contreras Z, Hoon M, Fink KD, Johansson HJ, Rossignol J, Dunbar GL, Showalter M, Fiehn O, Bramlett CS, Bardini RL, Bauer G, Fury B, Hendrix KJ, et al. Mesenchymal stem cell-based therapy for ischemic stroke Chinese Neurosurgical Journal. 2. DOI: 10.1186/S41016-016-0053-4 |
0.651 |
|
2010 |
Velichko S, Anderson J, Zhou W, Ryan S, Huang F, Wu R. PS1-80 Identification of a novel transcriptional regulatory mechanism for ACT1 Cytokine. 52: 34. DOI: 10.1016/J.Cyto.2010.07.152 |
0.705 |
|
Show low-probability matches. |